Department of Medicine

Basic scientists, clinical researchers, and clinicians in the Department of Medicine work side-by-side to address fundamental problems in human disease. Their collaborative efforts enable them to take mechanistic discoveries to preclinical testing and first-in-man clinical trials. Cross-cutting programs include regenerative medicine, vaccine testing and development, immunology and inflammation, outcomes and health services research, and the molecular basis of disease.

Support for Researchers

The Department of Medicine offers services and resources for investigators, including funding opportunities, training programs, and more.

We also offer event programming designed specifically for investigators at all stages of their research careers.

Explore Research by Division

The Department of Medicine's ten divisions have funded investigators who study clinically relevant questions from all perspectives.

Research Centers and Institutes

We operate world-renowned research centers for basic, translational, and clinical research related to physiology, therapeutics, and diseases pathogenesis.

Clinical Trials

We are proud to offer a large number of clinical trials for patients and potential patients.

Contact Us

View a list of relevant contacts for the Department of Medicine's Office of Research.

COVID-19 Research Resource Database

The National Institutes of Health National Institute on Aging has awarded $2,224,871 to a research team in the Division of Geriatrics and Gerontology.

The team, led by 
Molly Perkins, PhD, associate professor of medicine, is investigating informal caregiver involvement in end-of-life care of persons with advanced dementia in assisted living.

FY22 Research by the Numbers

$252.9 million in research funding

1,209 faculty publications from 418 contributing faculty

17 active NIH K awards and 62 active R01s

428 active clinical trials with 9,526 enrollees

Featured Story Preparing for the Next Pandemic

When the COVID-19 pandemic struck the United States in early 2020, the early hope that the new coronavirus would be no more transmissible than seasonal influenza was quickly dashed as infections spread like wildfire and death rates soared.

“We thought we were prepared as a country to fight a pandemic,” says Carlos del Rio, MD, distinguished professor of medicine and professor of global health and epidemiology. “Once the rubber hit the road, it became apparent we were not.”

Research Events

Loading Events...